Identifying compounds that interact with key AD-related targets, such as AChE, APP, BACE1, MAPT, PSEN1, TNF-α, and VCP, highlights their probable influence on critical pathways central to AD pathogenesis. Here, MAPT is linked to Alzheimer disease.